Skip to content Skip to sidebar Skip to footer

Undervalued Stocks

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

There are hard questions investors need to ask about their portfolio every now and again, because anyone telling you there's such a thing as a 'set and forget' investment is wrong. Markets evolve, company fundamentals shift, and macro conditions change, yet many portfolios are left largely unchecked. The most rational approach is to periodically interrogate…

ByNick SundichMarch 31, 2026

Data#3 (ASX:DTL): Another Quiet Compounder Confronting an Uncomfortable Question

Some ASX companies little fanfare and consistent long-term returns and Data#3 (ASX:DTL) is a textbook example. For nearly three decades as a listed company, it has grown steadily, paid reliable dividends, and rarely generated the kind of excitement that draws retail investors in large numbers. That obscurity may now be changing not because the business has…

ByNick SundichMarch 26, 2026

Turners Automotive (ASX:TRA): A Great 5-Year Track Record, But Will The Run Continue?

If you want a lesson in how a New Zealand company can quietly and consistently build shareholder wealth, look no further than Turners Automotive (ASX:TRA). On Tuesday March 24, the group held its 2026 Investor Day in Auckland and what was on show was not just a company that has executed well. It was a company…

ByNick SundichMarch 25, 2026

The Impact of The Iran War Extends Beyond Oil, And this ASX Company is the Poster Child for It!

It is easy to think the Impact of The Iran War is simply businesses in the oil space or that use oil in their operations (for instance freight businesses). Or by extension, companies in the 'consumer discretionary' space that find due to higher energy prices (and interest rates), that their goods are more discretionary than…

ByNick SundichMarch 25, 2026

Synlait (ASX:SM1): You Can’t Fault Management’s Honesty, But Can You Have Hope?

There is a particular kind of corporate announcement that arrives not with spin, but with a kind of exhausted candour, and we saw just this when Synlait issued its 1H26 result yesterday. "We are not going to attempt to dress things up," wrote Chair George Adams and CEO Richard Wyeth in their joint letter to shareholders…

ByNick SundichMarch 24, 2026

Core Lithium’s Finniss Lithium Project Is Go! And Glencore is Helping With the Restart!

An FID (Final Investment Decision) has been made on Core Lithium's (ASX:CXO) Finniss Lithium Project. With this news, and the securing of a US$120m/A$170m funding package, it is a great day to be a Core Lithium shareholder. What are the Best ASX stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] Recap of Core…

ByNick SundichMarch 18, 2026

The Looming Demotion: Here’s Why These 8 ASX Stocks Are Being Removed from the ASX All Ords!

In a couple of weeks, some ASX Stocks Are Being Removed from the ASX All Ords. Other companies will take their place and it was only yesterday that we wrote about that fact and some of the companies being promoted. But today it is time to look at the stocks suffering the indignity of being…

ByNick SundichMarch 13, 2026

ASX All Ordinaries Stocks: Here’s Why These 8 Companies Joined the Club In the Latest Rebalance!

Twice a year, specifically on the third Fridays of March and September, the list of ASX All Ordinaries Stocks changes as stocks are added and demoted. Their promotions and demotions happen for various reasons that all feed into an increase or decrease in the company's market capitalisation. In this article, we look at 8 companies that…

ByNick SundichMarch 12, 2026

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

In all our years, we have seen our fair share of ASX Company Spin. It is repeated because often investors fall for it. Even if not all do, it is sufficient that some investors fall for it to achieve what has to be achieved. For instance, that enough believe a capital raising at a >25% discount…

ByNick SundichFebruary 19, 2026

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Investors may remember Rhythm Biosciences (ASX:RHY) for its ColoSTAT test, but it is Genetype that is arguably more exciting. The company now has a substantially larger market awaiting us, and while its commercialisation strategy for ColoSTAT has changed, this strategy has been successful. Wait, has Rhythm received TGA approval? Yes and no - it's a long…

ByNick SundichFebruary 17, 2026

the Kick-ass Multipurpose WordPress Theme

Undervalued Stocks

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

Data#3 (ASX:DTL): Another Quiet Compounder Confronting an Uncomfortable Question

Turners Automotive (ASX:TRA): A Great 5-Year Track Record, But Will The Run Continue?

The Impact of The Iran War Extends Beyond Oil, And this ASX Company is the Poster Child for It!

Synlait (ASX:SM1): You Can’t Fault Management’s Honesty, But Can You Have Hope?

Core Lithium’s Finniss Lithium Project Is Go! And Glencore is Helping With the Restart!

The Looming Demotion: Here’s Why These 8 ASX Stocks Are Being Removed from the ASX All Ords!

ASX All Ordinaries Stocks: Here’s Why These 8 Companies Joined the Club In the Latest Rebalance!

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Undervalued Stocks

Add Your Heading Text Here